As part of an initiative to better understand and treat severe asthma, the National Heart, Lung, and Blood Institute (NHLBI) seeks applications for the Severe Asthma Research Program (SARP). The program will consist of six Clinical Centers, a Clinical Coordinating Center, and a Steering Committee.
SARP will develop a new paradigm for understanding severe asthma and its sub-phenotypes, in children and adults, by defining disease at the molecular and cellular level. Investigators will have an opportunity to work collaboratively across all participating centers, as well as create partnerships between asthma clinician-scientists and scientists with expertise in areas such as immunology, pulmonary physiology, molecular genetics, molecular phenotyping, imaging, and bioinformatics. The overall goal of the program is to enable prediction of phenotype stability/fluctuation and pharmacologic response, and to identify novel, disease-modifying targets for treatment.
For additional information about the types of opportunities available through this program, refer to the full announcement. Funding amounts vary. Applications for both Clinical Centers and the Clinical Coordinating Center are due October 15, 2010.
See the rest of this week’s Funding Alerts.